Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 5 Insider Annual Insider Trading Report
  12. 4/A Open-market buy 10% owner bought 272,727 shares at $11.00 ($2,999,997)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale 10% owner sold 8,100 shares at an average $7.62 ($61,723)
  15. 4 Open-market sale 10% owner sold 5,000 shares at an average $7.51 ($37,536)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale 10% owner sold 8,300 shares at an average $7.72 ($64,040)
  18. 4 Open-market sale 10% owner sold 15,900 shares at an average $7.76 ($123,452)
  19. 4 Open-market sale 10% owner sold 1,200 shares at $7.54 ($9,048)
  20. 4 Open-market sale 10% owner sold 2,000 shares at an average $7.75 ($15,500)

Page 13 of 15 · 287 filings